http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Altimmune Announces Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update
-
ABBYY’s Global Partner Program Grows 20% Boosting Customers’ Efficiency up to 80%
-
Aclaris Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Corporate Update
-
EchoStar Announces Financial Results for the Three and Twelve Months Ended December 31, 2024
-
Viatris Maintains Dividend Policy for 2025 and Announces Quarterly Dividend
-
Denison Reports CNSC Hearing Dates for Phoenix ISR Project
-
BeiGene Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates
-
Hyundai IONIQ 6 Named the Highest-Ranking Mass-Market BEV in J.D. Power 2025 U.S. Electric Vehicle Experience Ownership Study
-
Kovrr and metafinanz Announce Strategic Partnership to Strengthen Cyber Risk Quantification in the DACH Region
-
XRP Whales Flock To XRPTurbo Presale As 10% Of Soft Cap Fills Within Hours—Here’s Why You Can’t Miss It
-
Expro Wins Contract Supplying Tubular Running Services for Landmark Carbon Capture and Storage Project
-
Akeso Announces First ADC Drug Clinical Trial, Marking a New Era for "IO 2.0 + ADC" Strategy
-
Ericsson Annual Report 2024 published
-
Drill Contractor Engaged for "Case Lake West Cesium and Spodumene Pegmatite Project" in Ontario Bordering Power Metals Corp.'s Cesium Deposit
-
2025 CrowdStrike Global Threat Report: China’s Cyber Espionage Surges 150% with Increasingly Aggressive Tactics, Weaponization of AI-powered Deception Rises
-
Brainomix Partners with Medtronic to Enhance Stroke Care Across Western Europe
-
SES’s O3b mPOWER Now Providing Connectivity Services to Governments via NSPA’s MGS
-
SES Acknowledges Shareholder Announcement
-
RAMSAY SANTE :Ramsay Health Care Limited Financial advisor announcement - 27 February 2025
-
Belite Bio Announces Interim Analysis Results from the Pivotal Global Phase 3 DRAGON trial of Tinlarebant in Adolescent Stargardt Disease Subjects
-
Amaroq presents Nalunaq 2024 Exploration Results
-
argenx Reports Full Year 2024 Financial Results and Provides Fourth Quarter Business Update
-
iProov Issues Annual Identity Verification Threat Intelligence Report
-
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Western Asset Management Company LLC Mutual Fund Investors to Inquire About Securities Class Action Investigation - LAOIX, WATFX, WACPX
-
SQ, XYZ DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Block, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - SQ, XYZ
-
ROSEN, SKILLED INVESTOR COUNSEL, Encourages FTAI Aviation Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FTAI
-
Women of Global Change Philippines Chapter: Lighting Up Communities, Educating Families, and Create Sustainability
-
BIOA DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages BioAge Labs, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 10 Deadline in Securities Class Action -
-
Bitget Updates Proof of Reserves for February 2025, Reserve Ratios Increase to 186%
-
Bitget Updates Proof of Reserves for February 2025, Reserve Ratios Increase to 186%
-
ADTRAN Holdings, Inc. reports preliminary fourth quarter and full-year 2024 financial results
-
Women of Global Change Seattle: Igniting Transformation, Fighting Against Homelessness and Building Stronger Communities
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - GSK
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Crocs, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CROX
-
Women of Global Change Atlanta: Empowering Women, Transforming Communities, and Making a Difference
-
Global Leaders Unite in Riyadh to Chart New Course for Humanitarian Action
-
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Innovative Industrial Properties, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IIPR
-
ROSEN, LEADING TRIAL ATTORNEYS, Encourages ICON plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - ICLR
-
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Alarum Technologies Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALAR
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Grocery Outlet Holding Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GO
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Newmont Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - NEM
-
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Elastic N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ESTC
-
ROSEN, A LONGSTANDING LAW FIRM, Encourages Mullen Automotive, Inc. f/k/a Net Element, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MULN, NETE
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Dave Inc. Investors to Inquire About Securities Class Action Investigation - DAVE
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Polestar Automotive Holding UK PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - PSNY
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Tungray Technologies Inc Investors to Inquire About Securities Class Action Investigation - TRSG
-
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Intellia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NTLA
-
Nuns contribute 30 years of critical insight into dementia disorders, UT Health San Antonio study reveals
-
Mesoblast Sets Ryoncil® Price Based on Economic Value of Treatment With Planned Product Availability This Quarter

